Syncom Formulations (India) Limited (BOM: 524470)
India
· Delayed Price · Currency is INR 20.79
+0.53 (2.62%)
At close: Nov 14, 2024
Syncom Formulations (India) Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 3,289 | 2,634 | 2,243 | 2,197 | 2,448 | 2,055 | Upgrade
|
| Revenue Growth (YoY) | 35.89% | 17.45% | 2.09% | -10.27% | 19.12% | 10.03% | Upgrade
|
| Cost of Revenue | 2,036 | 1,580 | 1,424 | 1,409 | 1,624 | 1,526 | Upgrade
|
| Gross Profit | 1,253 | 1,054 | 818.18 | 787.32 | 824.5 | 529.2 | Upgrade
|
| Selling, General & Admin | 445.03 | 378.8 | 288.11 | 237.04 | 205.81 | 176.54 | Upgrade
|
| Other Operating Expenses | 419.41 | 380.78 | 335.19 | 350.92 | 240.3 | 185.39 | Upgrade
|
| Operating Expenses | 917.86 | 806.8 | 668.69 | 627.44 | 486.46 | 402.54 | Upgrade
|
| Operating Income | 334.95 | 247.51 | 149.49 | 159.87 | 338.04 | 126.66 | Upgrade
|
| Interest Expense | -26.53 | -43 | -29.9 | -18.28 | -1.93 | -5.47 | Upgrade
|
| Interest & Investment Income | 51.72 | 51.72 | 45.26 | 36.71 | 10.45 | 5.44 | Upgrade
|
| Currency Exchange Gain (Loss) | 23.17 | 23.17 | 40.81 | 31.95 | 9.07 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 52.78 | 52.78 | 58.25 | 51.1 | 50.08 | 46.78 | Upgrade
|
| EBT Excluding Unusual Items | 436.09 | 332.18 | 263.91 | 261.35 | 405.71 | 173.41 | Upgrade
|
| Gain (Loss) on Sale of Investments | 7.59 | 7.59 | 1.68 | 0.17 | 1.03 | - | Upgrade
|
| Other Unusual Items | -0.26 | -0.24 | 0.13 | 0.24 | 0.3 | -0.52 | Upgrade
|
| Pretax Income | 443.42 | 339.53 | 265.73 | 261.76 | 407.04 | 172.89 | Upgrade
|
| Income Tax Expense | 111.97 | 86.39 | 65.02 | 63.86 | 115.32 | 30.36 | Upgrade
|
| Net Income | 331.45 | 253.14 | 200.71 | 197.9 | 291.72 | 142.53 | Upgrade
|
| Net Income to Common | 331.45 | 253.14 | 200.71 | 197.9 | 291.72 | 142.53 | Upgrade
|
| Net Income Growth | 40.92% | 26.13% | 1.42% | -32.16% | 104.67% | 28.52% | Upgrade
|
| Shares Outstanding (Basic) | 923 | 940 | 929 | 817 | 781 | 838 | Upgrade
|
| Shares Outstanding (Diluted) | 923 | 940 | 929 | 873 | 809 | 838 | Upgrade
|
| Shares Change (YoY) | 5.20% | 1.24% | 6.34% | 7.93% | -3.51% | 5.84% | Upgrade
|
| EPS (Basic) | 0.36 | 0.27 | 0.22 | 0.24 | 0.37 | 0.17 | Upgrade
|
| EPS (Diluted) | 0.36 | 0.27 | 0.22 | 0.23 | 0.36 | 0.17 | Upgrade
|
| EPS Growth | 33.95% | 24.58% | -4.63% | -37.14% | 112.11% | 21.43% | Upgrade
|
| Free Cash Flow | -90.31 | -140.95 | -101.05 | 50.16 | -47.19 | 41.15 | Upgrade
|
| Free Cash Flow Per Share | -0.10 | -0.15 | -0.11 | 0.06 | -0.06 | 0.05 | Upgrade
|
| Dividend Per Share | - | - | - | 0.030 | - | - | Upgrade
|
| Gross Margin | 38.09% | 40.03% | 36.48% | 35.84% | 33.68% | 25.75% | Upgrade
|
| Operating Margin | 10.18% | 9.40% | 6.67% | 7.28% | 13.81% | 6.16% | Upgrade
|
| Profit Margin | 10.08% | 9.61% | 8.95% | 9.01% | 11.92% | 6.94% | Upgrade
|
| Free Cash Flow Margin | -2.75% | -5.35% | -4.51% | 2.28% | -1.93% | 2.00% | Upgrade
|
| EBITDA | 387.55 | 293.9 | 194.06 | 191.98 | 377.39 | 167.27 | Upgrade
|
| EBITDA Margin | 11.78% | 11.16% | 8.65% | 8.74% | 15.42% | 8.14% | Upgrade
|
| D&A For EBITDA | 52.61 | 46.39 | 44.57 | 32.11 | 39.35 | 40.61 | Upgrade
|
| EBIT | 334.95 | 247.51 | 149.49 | 159.87 | 338.04 | 126.66 | Upgrade
|
| EBIT Margin | 10.18% | 9.40% | 6.67% | 7.28% | 13.81% | 6.16% | Upgrade
|
| Effective Tax Rate | 25.25% | 25.44% | 24.47% | 24.39% | 28.33% | 17.56% | Upgrade
|
| Revenue as Reported | 3,424 | 2,769 | 2,389 | 2,317 | 2,519 | 2,107 | Upgrade
|
| Advertising Expenses | - | 19.43 | 18.29 | 5.01 | 0.96 | 5.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.